Lipigon Pharmaceuticals AB Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Lipigon Pharmaceuticals AB cash flow reinvestment rate. Lipigon Pharmaceuticals AB (LPGO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr1.06 Million. Explore LPGO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr1.06 Million
SEK
Capital Expenditures
Skr0.00
SEK
Lipigon Pharmaceuticals AB Cash Flow Reinvestment Rate by Year (None–None)
Lipigon Pharmaceuticals AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Lipigon Pharmaceuticals AB. For the full cash flow conversion analysis, see LPGO cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow